4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-24-021850
SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $61.40 ($1,228,020)
- SVP, CHIEF TECHNICAL OFFICER acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Option exercise 10b5-1 | +10,000 | $16.65 | $166,500 | 178,176 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Sale 10b5-1 | −10,000 | $61.06 | $610,550 | 168,176 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-21 | Option exercise 10b5-1 | +10,000 | $16.65 | $166,500 | 178,176 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-21 | Sale 10b5-1 | −9,900 | $61.74 | $611,236 | 168,276 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-21 | Sale 10b5-1 | −100 | $62.34 | $6,234 | 168,176 | D |
| Derivatives | |||||||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | 41,861 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-21 | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | 31,861 | D | ||
| Open-market sales · 20,000 sh · avg $61.40 · $1,228,020 | |||||||
Loading xslF345X05/form4-08212024_100827.xml…